Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05274022Not ApplicableCompleted

Rehabilitation Strategies to Improve Outcomes For Patients With a Lower Extremity Fracture

Role: lead

NCT07173088Not ApplicableRecruiting

Efficacy and Clinical Feasibility of the Ankle Muscle Power (AMP) Program for Return to Duty After an Ankle Fracture

Role: lead

NCT03364647Not ApplicableCompleted

The Effect of Various Strength Training Protocols in ACL Reconstructed Participants

Role: lead

All 3 trials loaded